Avantor is the lab's behind-the-scenes supplier, selling everything from chemicals and pipette tips to freezers and filtration systems to biotech and pharma researchers. Think of them as the industrial pantry for scientific discovery.
Revenue comes from recurring consumables and services, with gross margins around 32% and annual sales of USD 6.55B. The business is currently loss-making, with a net margin of -8.81%, though recent quarters show a return to small profits.
Switching costs are high because labs validate Avantor's materials into their workflows, and its catalog breadth makes one-stop shopping convenient. However, Thermo Fisher Scientific and Merck KGaA compete aggressively on price and innovation, eroding Avantor'
Buy (sector percentile 82) — value C+, growth C-, profitability C, momentum B+, revisions A+. Updated daily, sector-relative, identical for every user.
